{"schema_version":"1","generated_at":"2026-11-04T22:01:14.375Z","data_as_of":null,"url":"https://www.findmykol.com/kol/amanda-paschke","json_url":"https://www.findmykol.com/kol/amanda-paschke/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"amanda-paschke","name":"Amanda Paschke","credential":"MD","specialty":"Pediatric Infectious Diseases","specialty_raw":"Pediatric Infectious Diseases","therapeutic_area":"Infectious Disease","therapeutic_areas":["Infectious Disease"],"institution":"Merck & Co.","institution_url":"https://www.findmykol.com/institution/merck-co","city":"Philadelphia","state":"PA","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"}},"identifiers":{"npi":"1043400773","orcid":"0000-0002-0225-1802","openalex":"A5073235420"},"summary":"Amanda Paschke is an Infectious Disease physician affiliated with Merck & Co.. OpenAlex indexes 44 publications with 3,585 citations (h-index 18).","overview":null,"focus":{"indications":[],"research_topics":["Infectious Disease"]},"scholarship":{"works_count":44,"cited_by_count":3585,"h_index":18,"latest_activity_year":2026,"source":"works"},"publications":{"total":44,"shown":5,"withheld":39,"matched_by":"OpenAlex author record","recent":[{"title":"Imipenem/cilastatin/relebactam treatment of hospital-acquired/ventilator-associated bacterial pneumonia caused by imipenem-nonsusceptible pathogens: Subgroup analysis and molecular characterization of isolates from the RESTORE-IMI 2 clinical study","year":2026,"journal":"PLoS ONE","source_url":"https://doi.org/10.1371/journal.pone.0357288","status":"verified"},{"title":"Phase 2/3, Open-label, Randomized, Active-controlled Clinical Trial Evaluating the Safety and Efficacy of Imipenem/Cilastatin/Relebactam in Pediatric Patients From Birth to Less Than 18 Years With Gram-negative Bacterial Infections","year":2026,"journal":"The Pediatric Infectious Disease Journal","source_url":"https://doi.org/10.1097/inf.0000000000005323","status":"verified"},{"title":"Imipenem/cilastatin/relebactam dosing regimen justification using exposure–efficacy analyses in participants with hospital-acquired bacterial pneumonia or ventilator-associated bacterial pneumonia in the RESTORE-IMI 2 phase 3 study","year":2026,"journal":"Antimicrobial Agents and Chemotherapy","source_url":"https://doi.org/10.1128/aac.01313-25","status":"verified"},{"title":"Comparison of Molnupiravir Exposure‐Response Relationships for Virology Response and Mechanism of Action Biomarkers With Clinical Outcomes in Treatment of COVID ‐19","year":2025,"journal":"Clinical and Translational Science","source_url":"https://doi.org/10.1111/cts.70184","status":"verified"},{"title":"Impact of differences between interim and post-interim analysis populations on outcomes of a group sequential trial: Example of the MOVe-OUT study","year":2025,"journal":"Clinical Trials","source_url":"https://doi.org/10.1177/17407745251313925","status":"verified"}],"source":"works"},"similar":[{"name":"Ednan Bajwa","slug":"ednan-bajwa","institution":"Merck & Co.","specialty":"Pulmonary Disease","url":"https://www.findmykol.com/kol/ednan-bajwa","json_url":"https://www.findmykol.com/kol/ednan-bajwa/profile.json"},{"name":"Annaswamy Raji","slug":"annaswamy-raji","institution":"Merck & Co.","specialty":"Endocrinology, Diabetes & Metabolism","url":"https://www.findmykol.com/kol/annaswamy-raji","json_url":"https://www.findmykol.com/kol/annaswamy-raji/profile.json"},{"name":"Ritu Valiyil","slug":"ritu-valiyil","institution":"Merck & Co.","specialty":"Rheumatology","url":"https://www.findmykol.com/kol/ritu-valiyil","json_url":"https://www.findmykol.com/kol/ritu-valiyil/profile.json"},{"name":"Vassiliki Karantza-Wadsworth","slug":"vassiliki-karantza-wadsworth","institution":"Merck & Co.","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/vassiliki-karantza-wadsworth","json_url":"https://www.findmykol.com/kol/vassiliki-karantza-wadsworth/profile.json"},{"name":"Thomas Walsh","slug":"thomas-walsh","institution":"Cornell University","specialty":"Infectious Disease","url":"https://www.findmykol.com/kol/thomas-walsh","json_url":"https://www.findmykol.com/kol/thomas-walsh/profile.json"},{"name":"Douglas Richman","slug":"douglas-richman","institution":"University of California San Diego","specialty":"Infectious Disease","url":"https://www.findmykol.com/kol/douglas-richman","json_url":"https://www.findmykol.com/kol/douglas-richman/profile.json"},{"name":"Henry Masur","slug":"henry-masur","institution":"National Institutes of Health","specialty":"Infectious Disease","url":"https://www.findmykol.com/kol/henry-masur","json_url":"https://www.findmykol.com/kol/henry-masur/profile.json"},{"name":"Vance Fowler","slug":"vance-fowler","institution":"Duke University","specialty":"Infectious Disease","url":"https://www.findmykol.com/kol/vance-fowler","json_url":"https://www.findmykol.com/kol/vance-fowler/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"publications":39}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"}},"methodology_url":"https://www.findmykol.com/about#methodology"}